Biotech is well-known as the penny stock segment that can make the biggest short-term gains on good news. We all want to take advantage of these price spikes that can make us quick profits. Today, I’m talking about 2 Penny stocks with phase 3 results expected in Q2 2022 that you will want to watch closely. Today, I’m sharing the potential profits you can make from trading the news on these 2 stocks, and what to look for. So, stick around as I’m saving my top pick for last. TipRanks is forecasting a +694% growth target for the $0.55 stock over the next 12-months!
Click Here to watch the Video!